Abstract
Natural killer (NK) cells are defined by their ability to lyse certain tumour cells in vitro without previous exposure to them1–5, and have been postulated as effectors of immune surveillance against spontaneous neoplasms6. Because they kill some non-neoplastic lymphoid cells, they may also have a role in immunoregulation7,8. NK cell activity resides in a small proportion of normal mouse spleen cells (<5%) that have been difficult to characterize completely. They may represent a heterogeneous group of effector cells whose precise relationship to other myelopoietic or immunological cells has remained obscure9–12. We have previously described a cloned mouse cell line (Cl. Ly 1−2−NK-1+/11) with the functional characteristics of natural killer cells activated by interferon or other factors8. We now find that this cloned line, like basophils13,14 and mast cells15, expresses high-affinity plasma membrane receptors (FcɛR) specific for IgE antibody. In addition, the clone contains cytoplasmic granules similar by ultrastructure to those of basophils of the mouse and other species. Our findings indicate that cells sharing morphological and biochemical features of basophilic granulocytes can mediate NK lysis.
Similar content being viewed by others
References
Greenberg, A. M. & Playfair, J. H. L. Clin. exp. Immun. 16, 99–109 (1974).
Kiessling, R., Klein, E. & Wigzell, H. Eur. J. Immun. 5, 112–117 (1975).
Sendo, F., Aoki, T., Boyse, E. A. & Buafo, C. K. J. natn. Cancer Inst. 55, 603–609 (1975).
Herberman, R. B., Nunn, M. F., Holden, H. T. & Lavrin, D. H. Int. J. Cancer 16, 230–239 (1975).
Glimcher, L., Shen, F. W. & Cantor, H. J. exp. Med. 145, 1–9 (1977).
Roder, J. C. & Haliotis, T. Immun. Today 1, 96–100 (1980).
Hansson, M., Kiessling, R. & Andersson, B. Eur. J. Immun. 11, 8–12 (1981).
Nabel, G., Bucalo, L. R., Allard, J., Wigzell, H. & Cantor, H. J. exp. Med. 153, 1582–1591 (1981).
Herberman, R. B., Nunn, M. E. & Holden, H. T. J. Immun. 121, 304–309 (1978).
Roder, J. C. & Duwe, A. Nature 278, 451–453 (1979).
Knight, R. A. & Fitzharris, P. F. Br. J. Cancer 42, 243–251 (1980).
Herberman, R. B. & Ortaldo, J. R. Science 214, 24–30 (1981).
Ishizaka, T., Soto, C. & Ishizaka, K. J. Immun. 111, 500–511 (1973).
Malveaux, F. J., Conroy, M. C., Adkinson, N. F. Jr & Lichtenstein, L. M. J. clin. Invest. 62, 176–181 (1978).
Conrad, D. H., Bazin, H., Sehon, A. H. & Froese, A. J. Immun. 114, 1688–1691 (1975).
Reynolds, C. W., Timonen, T. & Herberman, R. B. J. Immun. 127, 282–287 (1981).
Timonen, T., Ortaldo, J. R. & Herberman, R. B. J. exp. Med. 153, 569–582 (1981).
Dvorak, A. M. et al. Lab. Invest. 44, 174–191 (1981).
Dvorak, A. M. in Immediate Hypersensitivity, Modern Concepts and Developments (ed. Bach, M. K.) 369–405 (Dekker, New York, 1978).
Galli, S. J. & Dvorak, H. F. in Cellular, Molecular and Clinical Aspects of Allergic Disorders (eds Gupta, S. & Good, R. A.) 1–53 (Plenum, New York, 1979).
Gonzales-Molina, A. & Spiegelberg, H. L. J. clin. Invest. 59, 616–624 (1977).
Anderson, C. L. & Spiegelberg, H. L. J. Immun. 126, 2470–2473 (1981).
Fritsche, R. & Spiegelberg, H. L. J. Immun. 121, 471–478 (1978).
Yodoi, J. & Ishizaka, K. J. Immun. 122, 2577–2583 (1980).
Melewicz, F. M., Zeiger, R. S., Mellon, M. H., O'Connor, R. D. & Spiegelberg, H. L. J. Immun. 126, 1592–1595 (1981).
Capron, M. et al. J. Immun. 126, 2087–2092 (1981).
Dvorak, A. M., Nabel, G., Pyne, K., Cantor, H., Dvorak, H. F. & Galli, S. J. Blood 59, 1279–1285 (1982).
Nabel, G., Galli, S. J., Dvorak, A. M., Dvorak, H. F. & Cantor, H. Nature 291, 332–334 (1981).
Nable, G., Fresno, M., Chessman, A. & Cantor, H. Cell 23, 19–28 (1981).
Roder, J. C., Kiessling, R., Biberfield, P. & Anderson, B. J. Immun. 121, 2509–2517 (1978).
Lohmann-Matthes, M.-L., Domzig, W. & Roder, J. J. Immun. 123, 1883–1886 (1979).
Oehl, S., Schaefer, K. W., Boecker, W. R., Kalden, J. R. & Peter, H. H. Z. immun. Forsch. 152, 423–430 (1977).
Kalden, J. R., Peter, H. H., Roubin, R. & Cesarini, J.-P. Eur. J. Immun. 7, 537–543 (1977).
Nabel, G., Greenberger, J. S., Sakakeeny, M. A. & Cantor, H. Proc. natn. Acad. Sci. U.S.A. 78, 1157–1161 (1981).
Sterk, A. & Ishizaka, T. J. Immun. 128, 838–843 (1982).
Kulczycki, A. & Metzger, H. J. exp. Med. 140, 1676–1695 (1974).
Liu, F.-T. et al. J. Immun. 124, 2728–2737 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Galli, S., Dvorak, A., Ishizaka, T. et al. A cloned cell with NK function resembles basophils by ultrastructure and expresses IgE receptors. Nature 298, 288–290 (1982). https://doi.org/10.1038/298288a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/298288a0
- Springer Nature Limited
This article is cited by
-
IgE and Immune Defense Mechanism
Clinical Reviews in Allergy (1989)
-
Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines
CANCER AND METASTASIS REVIEW (1984)
-
Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells
Nature (1983)